Can Fetal Ascitic Fluid Be Used for Chromosomal Microarray and FISH Analysis?
Fetal ascitic fluid is not a standard specimen for chromosomal microarray analysis (CMA) or FISH, and current ACMG guidelines do not address its use—standard prenatal diagnostic testing should utilize amniotic fluid or chorionic villus sampling (CVS) instead.
Standard Specimen Requirements
The most recent ACMG guideline from 2017 1 explicitly states that diagnostic prenatal testing should be performed on either CVS or amniotic fluid samples. These are the only specimen types validated and recommended for:
- Chromosomal microarray analysis (CMA) for detecting copy number variations and aneuploidies
- FISH analysis for rapid aneuploidy detection
- Standard karyotyping for comprehensive chromosomal analysis
Why Amniotic Fluid and CVS Are Standard
These specimens contain viable fetal cells that can be:
- Cultured for traditional karyotyping
- Analyzed directly for CMA with reliable DNA quality
- Used for interphase FISH with established protocols and quality controls 1
Research confirms that amniotic fluid performs well for both CMA (detecting 85% of cases successfully) and FISH analysis 2, with established protocols for both fresh and even refrigerated samples 3.
The Problem with Ascitic Fluid
Fetal ascitic fluid is not mentioned in any ACMG guidelines as an acceptable specimen type. Critical concerns include:
- No validated protocols for cell culture or DNA extraction from ascitic fluid
- Unknown cell viability and concentration for analysis
- Potential contamination with maternal cells or other body fluids
- Lack of quality control standards specific to this specimen type
- No established interpretation criteria for results
Technical Limitations of FISH
Even with standard specimens, the 1993 ACMG FISH policy statement 4 emphasizes that FISH should only be used as an adjunct test, not stand-alone, because:
- It cannot detect structural chromosomal rearrangements
- It has a 10-15% uninformative rate
- Results require confirmation with standard karyotyping
- Patient management decisions should never be based on FISH alone
Recommended Approach
If fetal ascites is detected on ultrasound and genetic testing is indicated:
- Perform standard amniocentesis to obtain amniotic fluid for comprehensive testing
- Use CMA as the primary diagnostic test for detecting aneuploidies and pathogenic CNVs 1
- Consider FISH for rapid preliminary results if time-sensitive decisions are needed, but always confirm with full analysis 1
- Reserve karyotyping to evaluate structural rearrangements when CMA shows abnormalities 1
Critical Caveat
The presence of fetal ascites itself may indicate underlying chromosomal abnormalities or other genetic conditions. This makes obtaining proper diagnostic specimens even more critical—attempting to use ascitic fluid without validated protocols could lead to false-negative results, delayed diagnosis, and compromised patient counseling.
Bottom line: Use standard amniocentesis for all prenatal genetic testing. There is no evidence supporting the use of fetal ascitic fluid for CMA or FISH analysis, and deviating from established protocols could compromise diagnostic accuracy and patient outcomes.